Salil Shukla, MD
NPI 1154595171ActiveIndividual· Ophthalmology, Retina Specialist· Golden, CO
Ophthalmology, Retina Specialist (MD) in Golden, Colorado, trained at New York Medical College (class of 2004). In 2024 Medicare paid $3,646,176 for 781 patients, and Part D covered 162 of their prescriptions, 77% of them generic. Genentech, Inc. was the largest of 10 companies reporting payments in 2025, $1,463 in all, mostly food and beverage.
Overview
| NPI | 1154595171 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Apr 22, 2008 |
| Last updated in NPPES | Mar 11, 2020 |
| Certified by provider | Mar 11, 2020 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Ophthalmology, Retina Specialist Primary | 207WX0107X | 49167 | CO |
| Ophthalmology | 207W00000X | 0049167 | CO |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Ophthalmology (CO) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 781 |
|---|---|
| Services billed | 36,196 across 43 procedure codes |
| Paid by Medicare | $3,646,176 |
Part D prescriptions in 2024
| Prescriptions (claims) | 162 · 184 30-day fills |
|---|---|
| Patients | 113 |
| Total drug cost | $15,398 |
| Generic share | 77% of claims |
Education and affiliations
| Medical school | New York Medical College |
|---|---|
| Graduation year | 2004 |
| Medicare specialty | Ophthalmology |
Medical group
- Colorado Retina Associates, PLLCLakewood, CO · 15 clinicians
Industry payments (Open Payments)
- 2025$1,463 · 37 payments from 10 companies
- 2024$1,164 · 33 payments from 8 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Genentech, Inc. | $401.30 | 2 |
| Regeneron Healthcare Solutions, Inc. | $282.09 | 6 |
| Astellas Pharma Global Development | $164.06 | 1 |
| Apellis Pharmaceuticals, Inc. | $156.93 | 6 |
| Genentech USA, Inc. | $139.88 | 6 |
What the 2025 payments were for
- Food and Beverage$1,463 · 37 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records